#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14504	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2137	673.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	851	C,A	802,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26780	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3710	720.2	0	.	n	.	0	T695C	SNP	695	695	T	1092	1092	C	791	C,T,G	745,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26780	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3710	720.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1734	1734	A	894	A,G	849,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26780	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3710	720.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2368	2368	C	860	C,T	798,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26780	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3710	720.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2994	2994	T	849	T,C	805,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26780	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3710	720.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2442	2442	A	894	A	853	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	V36A	NONSYN	106	108	GTG	405	407	GCG	199;198;198	G;C;G	187;190;188	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	447	449	CGG	210;211;209	C;G;G	196;199;195	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	S68L	NONSYN	202	204	TCG	501	503	TTG	182;183;180	T,G;T;G	167,1;170;172	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	A90V	NONSYN	268	270	GCG	567	569	GTT	164;164;163	G;T;T	152;147;150	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	I105V	NONSYN	313	315	ATT	612	614	GTT	162;162;161	G;T;T	153;150;153	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	N125T	NONSYN	373	375	AAT	672	674	ACC	187;185;186	A;C;C	171;172;173	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	R135C	NONSYN	403	405	CGT	702	704	TGT	184;183;185	T;G;T	170;167;169	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	K151E	NONSYN	451	453	AAA	750	752	GAA	174;172;173	G;A;A	163;160;161	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	T152N	NONSYN	454	456	ACC	753	755	AAC	172;171;172	A;A;C	160;158;159	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	A172T	NONSYN	514	516	GCG	813	815	ACA	155;155;157	A;C;A	148;149;145	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	A175E	NONSYN	523	525	GCG	822	824	GAA	148;150;151	G;A;A	143;142;143	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	E176T	NONSYN	526	528	GAA	825	827	ACC	152;152;151	A;C;C	145;144;142	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	I178V	NONSYN	532	534	ATC	831	833	GTC	148;149;150	G;T;C	140;144;143	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	I188T	NONSYN	562	564	ATA	861	863	ACG	158;157;156	A;C;G	145;144;144	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	P200N	NONSYN	598	600	CCC	897	899	AAC	145;145;146	A;A;C	142;139;142	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	F220L	NONSYN	658	660	TTT	957	959	TTG	158;158;156	T;T;G	148;146;143	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	A239T	NONSYN	715	717	GCA	1014	1016	ACC	146;145;145	A;C,G;C	139;137,1;139	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	N240D	NONSYN	718	720	AAT	1017	1019	GAC	143;142;143	G;A;C	136;135;134	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1026	1028	GCG	148;149;147	G;C;G	139;120;138	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1062	1064	GCT	131;134;135	G;C,G;T	125;126,1;128	.	.
folP.Neisseria_meningitidis_MC58_v2_01707	folP.Neisseria_meningitidis_MC58_v2_01707	1	1	539	1696	folP	858	858	91.61	folP.l15.c4.ctg.1	1540	109.7	1	SNP	p	R230S	1	.	.	688	690	AGC	987	989	AGC	172;172;172	A,C;G;C	164,1;164;165	folP.Neisseria_meningitidis_MC58_v2_01707:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5500	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3514	156.1	1	SNP	p	S91F	0	.	.	271	273	TCC	600	602	TCC	193;193;193	T;C;C	178;180;175	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5500	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3514	156.1	1	SNP	p	D95G	0	.	.	283	285	GAC	612	614	GAC	194;195;195	G;A;C	175;172;179	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5500	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3514	156.1	1	SNP	p	D95N	0	.	.	283	285	GAC	612	614	GAC	194;195;195	G;A;C	175;172;179	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	1730	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1343	128.2	1	SNP	p	G45D	1	.	.	133	135	GAC	514	516	GAC	221;220;222	G;A;C	205;202;204	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	912	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1109	82.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5254	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	175.5	1	SNP	p	D86N	0	.	.	256	258	GAC	588	590	GAC	175;174;173	G;A;C	164;163;163	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5254	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	175.5	1	SNP	p	S87I	0	.	.	259	261	AGT	591	593	AGT	177;178;179	A;G;T	170;166;168	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5254	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	175.5	1	SNP	p	S87R	0	.	.	259	261	AGT	591	593	AGT	177;178;179	A;G;T	170;166;168	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5254	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	175.5	1	SNP	p	S87W	0	.	.	259	261	AGT	591	593	AGT	177;178;179	A;G;T	170;166;168	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5254	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2981	175.5	1	SNP	p	S88P	0	.	.	262	264	TCC	594	596	TCC	180;184;183	T;C;C	170;173;172	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4276	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2652	160.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1512	1514	GGC	222;220;218	G,A;G;C	211,1;213;207	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2365	160.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1283	1285	GCA	205;202;202	G,T;C;A	189,1;189;191	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2365	160.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1286	1288	ATC	203;204;205	A;T;C	194;195;195	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2365	160.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1298	1300	GTG	194;196;197	G;T;G	183;183;186	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2365	160.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1298	1300	GTG	194;196;197	G;T;G	183;183;186	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2365	160.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1802	1804	ACC	187;187;189	A;C;C	175;175;177	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2365	160.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1856	1858	GCG	175;175;177	G;C;G	158;141;155	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2365	160.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1856	1858	GCG	175;175;177	G;C;G	158;141;155	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2365	160.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1979	1981	GGC	165;164;165	G;G;C	153;155;154	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2365	160.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1988	1990	GGC	166;165;162	G;G;C	150;147;145	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3810	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2365	160.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2006	2008	CCG	132;134;134	C,CGG;CG,CGGG;G	99,1;99,1;99	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5626	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3085	181.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1659	1661	CTG	234;236;234	C,T;T;G	215,1;221;215	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2550	porA	1146	1146	99.83	porA.l15.c30.ctg.1	1598	157.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	468	468	C	186	C	173	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	G38E	NONSYN	112	114	GGA	409	411	GAA	209;208;206	G;A;A	200;199;199	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	S46G	NONSYN	136	138	AGC	433	435	GGC	207;205;205	G;G;C	197;194;192	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	E48G	NONSYN	142	144	GAA	439	441	GGA	208;207;210	G;G;A	196;190;198	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	T87A	NONSYN	259	261	ACT	556	558	GCT	183;182;184	G,A;C;T	169,1;170;166	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	T89S	NONSYN	265	267	ACC	562	564	AGC	188;187;189	A;G;C	172;172;172	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	.	MULTIPLE	358	359	AA	654	655	CG	211;214	C;G,A	193;195,1	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	.	MULTIPLE	361	362	GA	657	659	CAG	214;212;211	C;A;G	194;193;192	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	N122K	NONSYN	364	366	AAC	661	663	AAA	209;205;204	A;A;A	193;189;189	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	K143E	NONSYN	427	429	AAA	724	726	GAA	198;196;200	G;A;A	191;189;193	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	V151A	NONSYN	451	453	GTA	748	750	GCA	207;205;204	G;C;A	189;189;186	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	A215T	NONSYN	643	645	GCT	940	942	ACT	190;189;188	A;C;T	179;178;177	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	I218M	NONSYN	652	654	ATA	949	951	ATG	181;180;182	A;T,A;G	170;169,1;171	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1063	1065	GCA	183;183;187	G;C,G;A	172;171,1;176	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1066	1068	ACG	188;185;186	A;C;G	178;174;173	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	S258G	NONSYN	772	774	AGT	1069	1071	GGG	187;189;189	G;G;G	173;176;178	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1072	1074	GTT	190;191;195	G;T,G;T	180;178,1;183	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1132	1134	GTA	209;206;205	G;T;A	197;194;193	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1171	1173	ACT	195;194;194	A;C;T	182;182;184	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1177	1179	GAT	191;188;187	G;A;T	182;181;179	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1189	1191	CAC	180;182;183	C;A;C	173;173;179	.	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	1	SNP	p	G120K	1	.	.	358	360	AAG	654	656	CGG	211;214;212	C;G,A;G	193;195,1;193	porB1b.WHO_L_01891c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	1	SNP	p	D121N	0	.	.	361	363	GAC	657	660	CGC	214;211;208	C;G;C	194;192;192	porB1b.WHO_L_01891c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_L_01891c	porB1b.WHO_L_01891c	1	1	539	2540	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1487	169.7	1	SNP	p	A121D	1	.	.	361	363	GAC	657	660	CGC	214;211;208	C;G;C	194;192;192	porB1b.WHO_L_01891c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9814	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4922	198.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2034	2036	CAT	212;210;209	C;A;T	193;193;191	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1138	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	962	116.9	1	SNP	p	V57M	1	.	.	169	171	ATG	500	502	ATG	225;222;219	A;T;G	211;210;207	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
